Neurocrine Biosciences Inc (NBIX)

Apr 05, 2026

Nisa Investment Advisors Reduces Neurocrine Biosciences Stake - National Today

Apr 05, 2026

Apr 05, 2026

Nisa Investment Advisors LLC Sells 21,945 Shares of Neurocrine Biosciences, Inc. $NBIX - MarketBeat

Apr 05, 2026

Apr 05, 2026

Risks Report: Is Neurocrine Biosciences Inc a turnaround storyMarket Weekly Review & High Win Rate Trade Tips - baoquankhu1.vn

Apr 05, 2026

Apr 04, 2026

Neurocrine Biosciences, Inc. (NASDAQ: NBIX) Q4 2025 earnings call transcript - MSN

Apr 04, 2026

Apr 04, 2026

A Look At Neurocrine Biosciences (NBIX) Valuation After New INGREZZA Data In Older Tardive Dyskinesia Patients - Sahm

Apr 04, 2026

Apr 04, 2026

Should You be Optimistic on Neurocrine Biosciences (NBIX)? - MSN

Apr 04, 2026

Apr 03, 2026

Neurocrine Biosciences Experiences Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo

Apr 03, 2026

Apr 03, 2026

NBIX Financials: Revenue Breakdown, Margins & Competitor Comparison - intellectia.ai

Apr 03, 2026

Apr 02, 2026

8,437 Shares in Neurocrine Biosciences, Inc. $NBIX Acquired by Nilsine Partners LLC - MarketBeat

Apr 02, 2026

Apr 02, 2026

Neurocrine Biosciences, Inc. $NBIX Shares Sold by Allspring Global Investments Holdings LLC - MarketBeat

Apr 02, 2026

Apr 02, 2026

Neurocrine Biosciences, Inc. (NBIX) Stock forecasts - Yahoo Finance UK

Apr 02, 2026

Apr 02, 2026

What Neurocrine Biosciences (NBIX)'s New Senior TD Data and Guidelines Could Mean For Shareholders - Sahm

Apr 02, 2026

Apr 01, 2026

NBIX Technical Analysis & Stock Price Forecast - intellectia.ai

Apr 01, 2026

Mar 31, 2026

Neurocrine Biosciences Inc (NBIX) Shares Up 3.15% on Mar 31 - GuruFocus

Mar 31, 2026

Mar 31, 2026

Responsive Playbooks and the NBIX Inflection - Stock Traders Daily

Mar 31, 2026

Mar 30, 2026

Neurocrine Biosciences Inc (NBIX) Shares Down 3.14% on Mar 30 - GuruFocus

Mar 30, 2026

Mar 30, 2026

Needham bullish on Neurocrine Biosciences, Inc. (NBIX) pipeline amid 2026 growth expectations for Crenessity and Ingrezza - MSN

Mar 30, 2026

Mar 29, 2026

NBIX SEC FilingsNeurocrine Biosciences Inc 10-K, 10-Q, 8-K Forms - Stock Titan

Mar 29, 2026

Mar 29, 2026

Neurocrine Biosciences Stock: A Leader in Neurological and Endocrine Therapies with Strong US Market - AD HOC NEWS

Mar 29, 2026

Mar 29, 2026

Wealth Enhancement Advisory Services LLC Boosts Stake in Neurocrine Biosciences, Inc. $NBIX - MarketBeat

Mar 29, 2026

Mar 28, 2026

Free cash flow per share of Neurocrine Biosciences, Inc. – DUS:NB3 - TradingView

Mar 28, 2026

Mar 28, 2026

SG Americas Securities LLC Buys 119,339 Shares of Neurocrine Biosciences, Inc. $NBIX - MarketBeat

Mar 28, 2026

Mar 28, 2026

Nordea Investment Boosts Stake in Neurocrine Biosciences - National Today

Mar 28, 2026

Mar 28, 2026

Nordea Investment Management AB Increases Stake in Neurocrine Biosciences, Inc. $NBIX - MarketBeat

Mar 28, 2026

Mar 28, 2026

Assenagon Asset Management S.A. Has $11.35 Million Stock Position in Neurocrine Biosciences, Inc. $NBIX - MarketBeat

Mar 28, 2026

Mar 27, 2026

[SCHEDULE 13G/A] NEUROCRINE BIOSCIENCES INC Amended Passive Investment Disclosure - Stock Titan

Mar 27, 2026

Mar 27, 2026

Neurocrine (NASDAQ:NBIX) Expands Clinical Strategy As Nasdaq Futures Shift - Kalkine Media

Mar 27, 2026

Mar 27, 2026

Tudor Investment Corp ET AL Buys 23,893 Shares of Neurocrine Biosciences, Inc. $NBIX - MarketBeat

Mar 27, 2026

Mar 27, 2026

Is Geriatric-Focused INGREZZA Data Quietly Reframing Neurocrine Biosciences' Neurology Leadership Narrative (NBIX)? - Yahoo Finance

Mar 27, 2026

Mar 26, 2026

Neurocrine Biosciences Updates Tardive Dyskinesia Care And Valuation Story - simplywall.st

Mar 26, 2026

Mar 26, 2026

Neurocrine presents tardive dyskinesia treatment guidance for elderly - StreetInsider

Mar 26, 2026

Mar 26, 2026

Neurocrine Biosciences Presents First Expert Consensus Recommendations for Tardive Dyskinesia in Long-Term Care Settings - PR Newswire

Mar 26, 2026

Mar 26, 2026

Neurocrine Biosciences Inc (NBIX) Shares Up 3.53% on Mar 25 - GuruFocus

Mar 26, 2026

Mar 26, 2026

Earnings Miss: Why is Neurocrine Biosciences Inc stock going upProfit Target & Consistent Growth Equity Picks - baoquankhu1.vn

Mar 26, 2026

Mar 26, 2026

Shorts Report: Does Neurocrine Biosciences Inc have pricing powerTrend Reversal & Free Expert Approved Momentum Trade Ideas - baoquankhu1.vn

Mar 26, 2026

Mar 26, 2026

New long-term care guidance calls for quarterly tardive dyskinesia screening - Stock Titan

Mar 26, 2026

Mar 25, 2026

Neurocrine Biosciences Inc. (NASDAQ:NBIX) Presents a Strong Growth and Technical Setup - ChartMill

Mar 25, 2026

Mar 25, 2026

Truist lowers Neurocrine Biosciences, Inc.’s (NBIX) PT following 2026 outlook update - MSN

Mar 25, 2026

Mar 23, 2026

Biohaven Stock Down 70% but One Fund's New $6 Million Bet Signals Turnaround Potential - The Motley Fool

Mar 23, 2026

Mar 23, 2026

Neurocrine Biosciences, Inc.Common Stock (NQ: NBIX - FinancialContent

Mar 23, 2026

Mar 23, 2026

CIBC Private Wealth Group Boosts Neurocrine Biosciences Stock Holdings - National Today

Mar 23, 2026

Mar 23, 2026

CIBC Private Wealth Group LLC Grows Stock Position in Neurocrine Biosciences, Inc. $NBIX - MarketBeat

Mar 23, 2026

Mar 23, 2026

Assessing Neurocrine Biosciences (NBIX) Valuation As Shares Soften Despite Growing Revenue And Net Income - Sahm

Mar 23, 2026

Mar 21, 2026

Block Trades: Can Neurocrine Biosciences Inc be recession proofProfit Target & Long Hold Capital Preservation Plans - baoquankhu1.vn

Mar 21, 2026

Mar 21, 2026

Hedge Fund Bets: Can Neurocrine Biosciences Inc maintain its current growth rateWall Street Watch & Safe Entry Trade Signal Reports - baoquankhu1.vn

Mar 21, 2026

Mar 21, 2026

Neurocrine Biosciences, Inc. $NBIX Shares Sold by Hudson Bay Capital Management LP - MarketBeat

Mar 21, 2026